RELATED SOCIETY LINKS

Message sent on behalf of ESGICH

On behalf of ESGICH, we are pleased to invite you to an upcoming Clinical–Pathological Conference (CPC): ESGICH – CPC Webinar: Tuesday, March 10, 2026, at 12:00 PM ET: 

Toxoplasmosis Beyond Transplantation: Diagnostic and Prevention Challenges in Patients Receiving Targeted Immunomodulators

As the landscape of immunomodulatory therapies rapidly expands—including CAR-T cell therapy, bispecific antibodies, and other targeted agents—opportunistic infections are increasingly being recognized outside traditional transplant populations. This CPC will explore the evolving risk of toxoplasmosis in these settings, focusing on mechanisms of immune dysregulation, diagnostic complexity, prevention strategies, and multidisciplinary management.

Moderator
Carlos A. Gomez, MD
Associate Professor, Transplant Infectious Diseases
University of Nebraska Medical Center (UNMC)
Omaha, Nebraska, USA

Case Presenter
Pr. Christelle Pomares, MD, PhD
Centre Hospitalier Universitaire de Nice
Laboratoire de Parasitologie-Mycologie
Université de la Côte d’Azur, Inserm U 1065
Hôpital de l’ARCHET
Nice, France

Discussants
Jose G. Montoya, MD
Medical Director
Dr. Jack S. Remington Laboratory for Specialty Diagnostics
Sutter Health, Palo Alto Medical Foundation
Palo Alto, CA, USA

Andrea Zimmer, MD
Associate Professor
Director, Oncology Infectious Diseases Program
University of Nebraska Medical Center (UNMC)
Omaha, Nebraska, USA

This session is designed for infectious diseases specialists, transplant physicians, hematologist-oncologists, immunologists, microbiologists, and all clinicians caring for immunocompromised hosts.

We encourage you to disseminate this announcement across your institutional, national, and international listservs and professional networks.

Registration is free. 

Registration link:
https://us06web.zoom.us/webinar/register/WN_xt2jg3vAQFCIiHpKJIescg#/registration